Monica Cantile

4.5k total citations
133 papers, 3.5k citations indexed

About

Monica Cantile is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Monica Cantile has authored 133 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 41 papers in Oncology and 35 papers in Cancer Research. Recurrent topics in Monica Cantile's work include Cancer-related molecular mechanisms research (21 papers), Cancer Cells and Metastasis (12 papers) and Developmental Biology and Gene Regulation (12 papers). Monica Cantile is often cited by papers focused on Cancer-related molecular mechanisms research (21 papers), Cancer Cells and Metastasis (12 papers) and Developmental Biology and Gene Regulation (12 papers). Monica Cantile collaborates with scholars based in Italy, Switzerland and United States. Monica Cantile's co-authors include Gerardo Botti, Clemente Cillo, Maurizio Di Bonito, Francesca Collina, Renato Franco, Giosuè Scognamiglio, A. Faiella, Edoardo Boncinelli, Margherita Cerrone and Giuseppina Liguori and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Oncogene.

In The Last Decade

Monica Cantile

128 papers receiving 3.4k citations

Peers

Countries citing papers authored by Monica Cantile

Since Specialization

Citations

This map shows the geographic impact of Monica Cantile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Cantile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Cantile more than expected).

Fields of papers citing papers by Monica Cantile

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Cantile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Cantile. The network helps show where Monica Cantile may publish in the future.

Co-authorship network of co-authors of Monica Cantile

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Cantile. A scholar is included among the top collaborators of Monica Cantile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Cantile. Monica Cantile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growth 2025 ·Bioactive Materials ·(unknown), Simona Camorani, Luis Exequiel Ibarra, Gabriella Pinto, Lisa Agnello, Sandra Albanese, (unknown), Anna Illiano, (unknown), Vincenzo Ambrosio, Giosuè Scognamiglio, Monica Cantile, Angela Amoresano, Monica Fedele, Antonella Zannetti, Laura Cerchia	2
2	A recombinant fragment antigen-binding (Fab) of trastuzumab displays low cytotoxic profile in adult human cardiomyocytes: first evidence and the key implication of FcγRIIA receptor 2024 ·Acta Pharmacologica Sinica ·(unknown), (unknown), (unknown), Vittoria Rago, Maria Concetta Granieri, (unknown), (unknown), (unknown), Cesare Indiveri, Raffaele Ronca, Monica Cantile, (unknown), Carmine Rocca, Tommaso Angelone	2
3	Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review) 2023 ·International Journal of Oncology ·Monica Cantile, Margherita Cerrone, Maurizio Di Bonito, (unknown), (unknown), Gerardo Ferrara, Alfredo Budillon	4
4	Recombinant humanized Fab fragments targeting the CFC domain of human Cripto-1 2023 ·Biochemical and Biophysical Research Communications ·Annamaria Sandomenico, (unknown), (unknown), Pier Paolo Olimpieri, (unknown), Valeria Cicatiello, Monica Cantile, (unknown), Antonio Leonardi, Sandro De Falco, Menotti Ruvo	1
5	Production in Bacteria and Characterization of Engineered Humanized Fab Fragment against the Nodal Protein 2023 ·Pharmaceuticals ·(unknown), (unknown), Angela Oliver, Monica Cantile, Pier Paolo Olimpieri, Antonio Leonardi, Menotti Ruvo, Annamaria Sandomenico	1
6	Aberrant Expression of Long Non Coding RNA HOTAIR and De-Regulation of the Paralogous 13 HOX Genes Are Strongly Associated with Aggressive Behavior of Gastro-Entero-Pancreatic Neuroendocrine Tumors 2021 ·International Journal of Molecular Sciences ·Annabella Di Mauro, Giosuè Scognamiglio, Gabriella Aquino, Margherita Cerrone, Giuseppina Liguori, (unknown), Maurizio Di Bonito, Monica Cantile, Gerardo Botti, Salvatore Tafuto, Fabiana Tatangelo	6
7	The Ratio of GrzB+ − FoxP3+ over CD3+ T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic Melanoma 2021 ·Cancers ·Giosuè Scognamiglio, Mariaelena Capone, Francesco Sabbatino, Annabella Di Mauro, Monica Cantile, Margherita Cerrone, Gabriele Madonna, Antonio Maria Grimaldi, Domenico Mallardo, Marco Palla, (unknown), Anna Maria Anniciello, Maurizio Di Bonito, Paolo A. Ascierto, Gerardo Botti	9
8	The Role of lncRNAs in Rare Tumors with a Focus on HOX Transcript Antisense RNA (HOTAIR) 2021 ·International Journal of Molecular Sciences ·Giuseppina Liguori, Margherita Cerrone, Annarosaria De Chiara, Salvatore Tafuto, (unknown), Gerardo Botti, Maurizio Di Bonito, Monica Cantile	10
9	AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer 2019 ·Cancers ·Francesca Collina, Lucia La Sala, Federica Liotti, Nella Prevete, Elvira La Mantia, Maria Grazia Chiofalo, Gabriella Aquino, Laura Arenare, Monica Cantile, Giuseppina Liguori, Francesca Di Gennaro, Luciano Pezzullo, Simona Losito, Giancarlo Vecchio, Gerardo Botti, Rosa Marina Melillo, Renato Franco	27
10	Noncoding RNAs as circulating biomarkers in osteosarcoma patients 2019 ·Journal of Cellular Physiology ·Gerardo Botti, Antonio Giordano, Florinda Feroce, (unknown), Monica Cantile	28
11	Interaction Proteomics Identifies ERbeta Association with Chromatin Repressive Complexes to Inhibit Cholesterol Biosynthesis and Exert An Oncosuppressive Role in Triple-negative Breast Cancer 2019 ·Molecular & Cellular Proteomics ·Elena Alexandrova, Giorgio Giurato, (unknown), (unknown), Jessica Lamberti, Maria Ravo, Francesca Rizzo, (unknown), Roberta Tarallo, Tuula A. Nyman, Francesca Collina, Monica Cantile, Maurizio Di Bonito, Gerardo Botti, Giovanni Nassa, Alessandro Weisz	20
12	Noncoding RNAs within the HOX gene network in tumor pathogenesis and progression 2018 ·Journal of Cellular Physiology ·Gerardo Botti, A. Chiara, Maurizio Di Bonito, Margherita Cerrone, Maria Gabriella Malzone, Francesca Collina, Monica Cantile	23
13	Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types 2016 ·International Journal of Molecular Sciences ·Giosuè Scognamiglio, A. Chiara, Maurizio Di Bonito, Fabiana Tatangelo, Simona Losito, (unknown), Rossella De Cecio, Crescenzo D’Alterio, Stefania Scala, Monica Cantile, Gerardo Botti	34
14	Metastatic salivary ductal carcinoma androgen receptor-positive with V600E BRAF gene mutation 2016 ·Rossella De Cecio, Monica Cantile, Franco Fulciniti, Francesca Collina, Giosuè Scognamiglio, Francesco Longo, Franco Ionna, Gerardo Botti, Simona Losito	1
15	Programmed death ligand 1 (PDL-1) expression in triple negative breast cancer cells: New proposal for a "tumor score" definition 2016 ·International Journal of Clinical and Experimental Pathology ·Maurizio Di Bonito, Giosuè Scognamiglio, Francesca Collina, Giuseppina Liguori, Monica Cantile, Gerardo Botti	2
16	Parallel determination of NeuroD1, Chromogranin-A, KI67 and androgen receptor expression in surgically treated prostate cancers 2011 ·International braz j urol ·Luca Cindolo, Monica Cantile, Renato Franco, Paolo Chiodini, (unknown), Iris Maria Forte, Inti Zlobec, (unknown), Gerardo Botti, Stefano Gidaro, Luigi Terracciano, Clemente Cillo	13
17	CXCL12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and CXCR4 positive circulating tumoral cells in lung draining venous blood 2011 ·European Journal of Cardio-Thoracic Surgery ·Renato Franco, Giuseppe Pirozzi, Stefania Scala, Monica Cantile, Giosuè Scognamiglio, Rosa Camerlingo, Gerardo Botti, Gaetano Rocco	32
18	Neuroendocrine Differentiation in Prostate Cancer: From Lab to Bedside 2007 ·Urologia Internationalis ·Luca Cindolo, Monica Cantile, Francis Vacherot, Stéphane Terry, Alexandre de la Taille	37
19	The HOX genes are expressed, in vivo, in human tooth germs: In vitro cAMP exposure of dental pulp cells results in parallel HOX network activation and neuronal differentiation 2005 ·Journal of Cellular Biochemistry ·Vincenzo D’Antò, Monica Cantile, Maria DʼArmiento, (unknown), Gianrico Spagnuolo, Luigi Terracciano, R Vecchione, Clemente Cillo	10
20	Homeobox Genes and Cancer 1999 ·Experimental Cell Research ·Clemente Cillo, A. Faiella, Monica Cantile, Edoardo Boncinelli	145

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact